Search
for

    Sort by

    Research 271–300 of 579

    1. SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA International Journal of Innovative Technologies in Social Science · 2025
    2. Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study Dermatology and Therapy · 2025
    3. O PROCESSO DE ENFERMAGEM NO TRANSPLANTE CAPILAR: O IMPACTO DOS CUIDADOS PERIOPERATÓRIOS LUMEN ET VIRTUS · 2025
    4. Journal of Population Therapeutics and Clinical Pharmacology 2025
    5. A Concise Review on Novel Drugs Applied in Treatment of Alopecia 2025
    6. Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey Clinical, cosmetic and investigational dermatology · 2024
    7. Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review PloS one · 2024
    8. El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura Revista Medicina Cutánea Ibero-Latino-Americana · 2022
    9. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 18 citations
    10. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 2 citations
    11. 600 Impact of baricitinib on work productivity and indirect costs in adult patients with atopic dermatitis: A meta-analysis of clinical trials Journal of Investigative Dermatology · 2023
    12. Pharmacologic inhibition of JAK-STAT signaling promotes hair growth Science Advances · 2015 · 159 citations
    13. Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata Frontiers in immunology · 2022 · 13 citations
    14. Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review 2023 · 2 citations
    15. A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes Journal of Clinical Medicine · 2025
    16. Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science Biomolecules · 2025
    17. P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis Poster presentations · 2024
    18. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition Nature medicine · 2014 · 701 citations
    19. Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases Cell · 2020 · 227 citations
    20. Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib Brain · 2019 · 95 citations
    21. JAK Inhibitors for Treatment of Alopecia Areata 2018 · 63 citations
    22. Expression profile analysis of microRNAs during hair follicle development in the sheep foetus Bioscience, biotechnology, and biochemistry · 2019 · 9 citations
    23. Immune therapies for alopecia areata: evidence and new perspectives Expert Review of Clinical Immunology · 2025 · 5 citations
    24. Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata Skin health and disease · 2023 · 4 citations
    25. Gut microbiome, metabolome and alopecia areata Frontiers in microbiology · 2023 · 2 citations
    26. Inibidores das Janus Associated Kinases na Terapêutica Farmacológica 2016 · 1 citations
    27. Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling International Journal of Molecular Sciences · 2026
    28. Periplaneta americana extract (L.) promotes hair regrowth in Alopecia areata mice by reducing inflammation and modulating skin microbiota Frontiers in Pharmacology · 2025
    29. Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo Current dermatology reports · 2017
    30. Use of Jak Inhibitors in the Treatment of Alopecia Areata Serbian Journal of Dermatology and Venerology · 2026